Differences in imeglimin response in subgroups of patients with type 2 diabetes stratified by data‐driven cluster analysis: A post‐hoc analysis of imeglimin clinical trial data

Documenti analoghi

• Gastrointestinal symptoms in patients receiving imeglimin in combination with metformin: A post‐hoc analysis of imeglimin clinical trial data
  di: Jumpei Ito, et al.
  Pubblicazione: (2024)
• Dual action of imeglimin on insulin secretion and sensitivity in type 2 diabetes
  di: Tsubasa Tajima, et al.
  Pubblicazione: (2026)
• Efficacy and safety of imeglimin add‐on to DPP ‐4 inhibitor therapy in Japanese patients with type 2 diabetes mellitus: An interim analysis of the randomised, double‐blind FAMILIAR trial
  di: Kohei Kaku, et al.
  Pubblicazione: (2025)
• Similarities and differences in the intestinal actions of metformin and imeglimin
  di: Kenji Sugawara, et al.
  Pubblicazione: (2025)
• Differential effects of imeglimin and metformin on insulin and incretin secretion—An exploratory randomized controlled trial
  di: Ryota Usui, et al.
  Pubblicazione: (2024)